RB
Renegade.bio offers rapid diagnostic testing utilizing PCR and serological methods to detect novel infectious diseases. This service addresses the urgent need for timely and affordable testing solutions in the face of emerging health threats.
Updated 2 months ago
Funding
$28.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Renegade.bio offers rapid diagnostic testing utilizing PCR and serological methods to detect novel infectious diseases. This service addresses the urgent need for timely and affordable testing solutions in the face of emerging health threats.